Study Stopped
Poor return rate/high dropout rate requiring alteration to study methodology
Evaluation of the Normal Range of Urinary Sodium Levels in Healthy Newborn Babies
USALTI
1 other identifier
observational
200
1 country
1
Brief Summary
Oral sodium supplementation is currently administered in cases of poor weight gain in infants particularly in patients who have undergone gastrointestinal surgical procedures. The decision to start oral supplementation is based on urinary sodium levels although the level at which to start treatment is variable as the range in normal, healthy infants is unknown. This study aims to ascertain the normal range of sodium in urine specimens collected from healthy newborn babies. It is believed that by increasing the level of salt in the intestine, glucose can be more easily be absorbed and therefore weight gain improved. Babies with conditions where they are at risk of salt depletion (i.e. those with a stoma) are currently administered oral sodium supplementation if they are failing to gain weight and have an associated 'low' urinary sodium level. Low levels of urinary sodium are considered to represent a state of low body sodium levels, as the kidneys attempt to reabsorb most of the sodium in the urine before it is excreted. Current practice varies widely as to the level below which treatment should be instigated. Some centres advise below 20 mmol/L (Birmingham Children's Hospital and Nottingham Children's Hospital guidelines), others below 10 mmol/L (University Children's Hospital, Zurich). In Glasgow, babies with poor weight gain are given sodium supplementation if urinary sodium levels are below 40 mmol/L. There are no documented ranges for the levels of urinary sodium in healthy, newborn babies. By determining the reference range of urinary sodium levels in healthy, term babies who are gaining weight appropriately, the investigators hope to be able to have a better understanding about both the level below which supplementation should be considered and the target range that should be aimed for.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2016
CompletedFirst Submitted
Initial submission to the registry
January 6, 2017
CompletedFirst Posted
Study publicly available on registry
January 10, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedMay 8, 2017
May 1, 2017
6 months
January 6, 2017
May 3, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Random urinary sodium concentration (mmol/L)
Approximately 6 weeks after birth - sample asked to be collected by parents at 6 weeks of age
Secondary Outcomes (2)
Weight velocity (by World Health Organization growth chart centiles)
Birth weight to weight at 6 weeks
Feeding practices - which milk type mothers use to feed their babies e.g. exclusive breastmilk, exclusive formula, mixed
At birth and 6 weeks
Eligibility Criteria
The population being studied is healthy term (37-41 week gestation) babies with no significant ante- or post-natal history born within the study period in a single maternity unit.
You may qualify if:
- Term (37-41 week gestation) infant
- Born at specified maternity unit within study period
- Uncomplicated pregnancy with no antenatal diagnosis
- Uncomplicated postnatal period: no admission to neonatal/special care unit
- Full enteral milk feeds since birth
You may not qualify if:
- \< 37/40 gestation or \> 41/40 gestation infants
- Antenatal diagnosis of congenital abnormality
- Postnatal admission to the neonatal unit/special care baby unit
- Period of total parenteral nutrition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal Hospital for Children Glasgow
Glasgow, South Lanarkshire, G51 4TF, United Kingdom
Related Publications (1)
Cullis PS, Cull F, Bruce G, Johnston A, Patel H, Jackson L, Galloway P, Walker G. Quantification of urinary sodium concentrations in term infants. Ann Clin Biochem. 2019 Mar;56(2):295-297. doi: 10.1177/0004563218796592. Epub 2018 Aug 21.
PMID: 30089406DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Honorary clinical lecturer
Study Record Dates
First Submitted
January 6, 2017
First Posted
January 10, 2017
Study Start
October 1, 2016
Primary Completion
April 1, 2017
Study Completion
April 1, 2017
Last Updated
May 8, 2017
Record last verified: 2017-05
Data Sharing
- IPD Sharing
- Will not share